Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for ...

Major updates include increasing vigilance related to antitrust and the DOJ’s blocking of UnitedHealth’s merger with Amedisys ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on BBIO stock, giving a Buy rating yesterday.Stay Ahead of the ...

Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) must pay $100M to four people who say they were sickened by exposure to toxic PCB chemicals ...

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...